Coming Soon

Phion Therapeutics Ltd

Registration Number NI645613

Trading name: Phion Therapeutics

Phion Therapeutics is a biotechnology company focused on developing innovative therapies for the treatment of bacterial infections. The company combines advanced drug discovery techniques with a commitment to addressing the challenges of antibiotic resistance.

Company Overview

Company Name
Phion Therapeutics Ltd
Registration Number
NI645613
Founded
08 May 2017
Age
7 years
Industry Region
Northern Ireland
Registered Postcode
BT7 1NF

Online Profile

Special Flags

Spinout Company
Public Funding Received

Public Funding for Phion Therapeutics Ltd

2023-08-01
Process Development and Stability of the RALA Peptide for mRNA Vaccines
Collaborative R&D
2023-06-01
A Therapeutic mRNA Vaccine for Prostate Cancer
Collaborative R&D
2022-04-01
A Peptide-mRNA Vaccine for Crimean-Congo Haemorrhagic Fever (CCHF)
Small Business Research Initiative
2021-11-01
A Therapeutic mRNA Vaccine for Ovarian Cancer
Feasibility Studies
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-04-01
Northern Alliance ATTC
Centres
2021-01-01
Development of a Therapeutic mRNA Vaccine for COVID-19 using pHion's Delivery Technology
Collaborative R&D
2020-10-01
Automated Production of RALA/Nucleic Acid Nanoparticles from Bench to Patient Dose
Collaborative R&D
2020-06-01
Transient knockdown of the ACE-2 Receptor using the RALA Technology for COVID-19
Feasibility Studies
2020-06-01
Additional Support Required for Project 105441 resulting from COVID-19 pandemic
Feasibility Studies
2020-02-01
A new approach for safe and effective human therapeutic gene editing
Study
2019-09-01
Development of a Therapeutic mRNA HPV Vaccine using Phion's Delivery Technology
Collaborative R&D
2019-06-05
Tumour Targeted Small Molecule Therapeutic (RALgem)
Collaborative R&D

Get notified when we’re launching.

Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.